Quantifying Gut Wall Metabolism: Methodology Matters Publication Quantifying Gut Wall Metabolism: Methodology Matters Certara2016 年 12 月 1 日
Pharmacokinetics of Oral Terbinafine in Adult Horses Publication Pharmacokinetics of Oral Terbinafine in Adult Horses The primary study objective was to compare the pharmacokinetics of p.o. terbinafine alone to p.o.…Certara2016 年 11 月 24 日
Vaccination Mitigates the Impact of PRRSv Infection on the Pharmacokinetics of Ceftiofur Crystalline-free Acid in Pigs Publication Vaccination Mitigates the Impact of PRRSv Infection on the Pharmacokinetics of Ceftiofur Crystalline-free Acid in Pigs The pharmacokinetics of intramuscularly administered ceftiofur crystalline-free acid (CCFA) were determined in pigs that were…Certara2016 年 11 月 24 日
Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept Publication Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept Certara2016 年 11 月 23 日
A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics Publication A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics Certara2016 年 11 月 17 日
Impact of Target-mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Publication Impact of Target-mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Certara2016 年 11 月 15 日
IVIVC Software – Achieving Regulatory, Formulation and Manufacturing Success Brochure IVIVC Software – Achieving Regulatory, Formulation and Manufacturing Success In vitro-in vivo correlation (IVIVC) is an important, predictive mathematical tool in drug development, used…Certara2016 年 11 月 8 日
Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug Blog Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug Drug development is becoming more complex than ever. Regulatory agencies expect sponsors to consider a…Certara2016 年 10 月 21 日
Certara Establishes Phoenix PK/PD Centers of Excellence in China and Japan Press Release Certara Establishes Phoenix PK/PD Centers of Excellence in China and Japan PRINCETON, NJ – Oct. 13, 2016 – Certara, the leading provider of decision support technology…Certara2016 年 10 月 13 日
Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’ Press Release Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’ PRINCETON, NJ – Oct. 6, 2016 – Certara announces that Kelley Kendle, president of Synchrogenix,…Certara2016 年 10 月 6 日